You are here: Homepage Sectorfocus Life Sciences
Life Sciences
Meest recente
1 naar 10 van 376
-
Artikel
Ingediend: 29 November 2013
A summary of whistleblowing in the life sciences sector - upcoming developments
-
Artikel
Ingediend: 26 November 2013
OHIM has issued a circular concerning a recent update of its Manual concerning Examination of Classification of Goods and Services.
-
Artikel
Ingediend: 26 November 2013
Court of Appeal Decision of 21 November 2013 in IPCom v HTC.
-
Artikel
Ingediend: 11 November 2013
Lundbeck requested that Arnold J recuse himself because an expert witness in the case had been his university supervisor. In refusing the application Arnold J explained the rules relating to judicial bias.
-
Artikel
Ingediend: 07 November 2013
The EU General Court has ruled that the OHIM Opposition Division and Board of Appeal erred in finding a low degree of similarity between the CULTRA (fig) and SCULPTRA trade marks.
-
Artikel
Ingediend: 07 November 2013
A review of the patentability of personalised medicine patent claims in the UK and Europe.
-
Artikel
Ingediend: 06 November 2013
13 questions and answers about the Unified Patent Court. This article forms part of our Unified Patent Court Toolkit.
-
Video Podcast
Ingediend: 31 October 2013
Simmons & Simmons partners Ombline Ancelin and Michael Gavey discuss the obstacles that online sales of medicines have faced – and continue to face - in France.
-
Seminar
Ingediend: 23 October 2013
Focus by regulators on market misconduct in all its forms continues, but the extent of co-operation between regulators and prosecutors, on a domestic and international level, is not always apparent. Our market misconduct specialists will guide you through the recent developments with a focus on cross-border issues.
-
Seminar
Ingediend: 23 October 2013
Focusing on what Hong Kong-based asset managers need to be aware of in relation to the AIFMD, FATCA, changes proposed by the SFC to the Professional Investor regime in Hong Kong, exemptions from registration as a Commodity Pool Operator, registration with the SEC as a Foreign Private Adviser and Regulation D filings in the United States.
1 naar 10 van 376